Coming soon!

Dr. Pad Chivukula is the co-founder of Arcturus Therapeutics and has served as the Chief Scientific Officer and Chief Operating Officer since 2013. With a deep foundation in nanoparticle technology, Dr. Chivukula leads Arcturus in discovering and developing transformative medicines for diseases with unmet needs. Since Arcturus’ founding, he has built and advanced the company’s research competencies and pipeline in the areas of RNA therapeutics and vaccines, integrating advanced therapeutic platforms, and streamlining innovative processes. Dr. Chivukula holds over 100 publications and patents.

Prior to Arcturus, Dr. Chivukula held key roles at Nitto, including Group Leader and Chief Scientist, where he led the polymeric RNAi research department. He holds a Ph.D. in Pharmaceutical Chemistry from the University of Utah, specializing in nanoparticle technology.